UK markets closed
  • FTSE 100

    7,032.30
    -46.12 (-0.65%)
     
  • FTSE 250

    22,948.83
    -101.67 (-0.44%)
     
  • AIM

    1,251.11
    +3.84 (+0.31%)
     
  • GBP/EUR

    1.1713
    -0.0024 (-0.20%)
     
  • GBP/USD

    1.3908
    -0.0050 (-0.35%)
     
  • BTC-GBP

    29,709.35
    -355.99 (-1.18%)
     
  • CMC Crypto 200

    955.03
    +5.13 (+0.54%)
     
  • S&P 500

    4,395.26
    -23.89 (-0.54%)
     
  • DOW

    34,935.47
    -149.03 (-0.42%)
     
  • CRUDE OIL

    73.81
    -0.14 (-0.19%)
     
  • GOLD FUTURES

    1,812.50
    -0.10 (-0.01%)
     
  • NIKKEI 225

    27,283.59
    -498.81 (-1.80%)
     
  • HANG SENG

    25,961.03
    -354.27 (-1.35%)
     
  • DAX

    15,544.39
    -96.11 (-0.61%)
     
  • CAC 40

    6,612.76
    -21.01 (-0.32%)
     

Global Efficacy Testing Market to Reach $796.7 Million by 2026

·26-min read

Abstract: Global Efficacy Testing Market to Reach $796. 7 Million by 2026 . Efficacy test evaluates the effectiveness of the product through a series of tests, including safety test, toxicology test, and stability test, in order to get better quantitative values in addition to proof of efficacy and safety, after which the product becomes suitable for commercialization.

New York, July 21, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Efficacy Testing Industry" - https://www.reportlinker.com/p05798446/?utm_source=GNW
Growth in the global market is being driven by regulations for the safety and efficacy of pharmaceutical products. Increasing support from governments across the world for pharmaceutical and biotechnology industries, coupled with increasing investments for research and development activities in these sectors contributes to market growth. Moreover, the growing application of antimicrobial efficacy testing for different types of medical devices, in cosmetic and pharmaceutical industries, and R&D investments in the life sciences space are anticipated to boost the market.

Amid the COVID-19 crisis, the global market for Efficacy Testing estimated at US$425.4 Million in the year 2020, is projected to reach a revised size of US$796.7 Million by 2026, growing at a CAGR of 10.7% over the analysis period. Consumables, one of the segments analyzed in the report, is projected to record a 11.4% CAGR and reach US$503.4 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 9.6% CAGR for the next 7-year period. Market growth is dominated by the consumables segment, which is attributed to continual demand for bulk procurement and regular purchases of consumables.

The U.S. Market is Estimated at $149.1 Million in 2021, While China is Forecast to Reach $107.7 Million by 2026

The Efficacy Testing market in the U.S. is estimated at US$149.1 Million in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$107.7 Million by the year 2026 trailing a CAGR of 12.3% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8% and 9.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.4% CAGR. The US dominates market growth due to heavy investments into research and development by several pharmaceutical vendors. Demand for efficacy testing in the US is further driven by stringent regulations for drug development, and increasing government funding for research activities in the area of life sciences. Growth in the Asia-Pacific region is attributed to the rising demand for pharmaceuticals in the region. Factors such as the rising geriatric population, growing incidence of chronic diseases, increasing consumer health awareness, and increased government expenditure on the region`s healthcare infrastructure as well as quality control safety testing outsourcing in the Asian countries.

Services Segment to Reach $112 Million by 2026

In the global Services segment, USA, Canada, Japan, China and Europe will drive the 9.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$50.9 Million in the year 2020 will reach a projected size of US$98.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$9.5 Million by the year 2026, while Latin America will expand at a 11.2% CAGR through the analysis period.
Select Competitors (Total 70 Featured)

  • Eurofins Scientific SE

  • Merck KGaA

  • WuXi AppTec

  • SGS S.A

  • bioMérieux

  • Charles River Laboratories Inc.

  • Pacific Biolabs Inc.




Read the full report: https://www.reportlinker.com/p05798446/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
A Prelude to Efficacy Testing
Global Efficacy Testing Market Poised for Steady Growth
US Dominates, Asia-Pacific to Witness Rapid Growth
Anti-microbial/Preservative Efficacy Testing to Register Rapid
Growth
Disinfectant Efficacy Testing Dominates

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Rising Importance of Preservative Efficacy Testing
Challenge Organisms
Testing Techniques
Challenges
Conclusion
Preservation Technique for Paraben-Free Cosmetics
Development of Alternative Techniques of Preservation
Adoption of Hurdle Technology
Preservative Systems in Liquid Dietary Supplements
Preservative Efficacy Test (PET) for Cosmetics
Efficacy Testing for Cosmetics
Techniques Employed for Demonstrating Effectiveness of
Disinfectants
Categorization of Test Types
Surface Testing
Additional Tests Mandated for the Pharmaceuticals Industry by
the USP
Contact Time Defined
Strong Rise in Pharmaceutical Sales to Drive Demand for
Efficacy Testing
EXHIBIT 1: Global Prescription Drug Sales (In US$ Billion) for
the Years 2017, 2019, 2021, 2023 & 2025
Rapid Growth of Generic Drugs Drives Demand for Pharma Efficacy
Testing
EXHIBIT 2: Global Generic Drugs Market Size (in $ Billion) for
the Years 2016, 2019, 2020 & 2025
Aging Population Propels the Demand for Ethicacy Testing in
End-use Applications
Global Aging Population Statistics for the 65+ Age Group in
Million by Geographic Region for the Years 2019, 2025, 2035
and 2050
Increasing Healthcare Expenditure to Foster Growth
World Healthcare Expenditure (In US$ Trillion) for the Years
2016 & 2018
Persistent Increase in Pharmaceutical R&D Bodes Well for
Efficacy Testing
Rising Incidence of Chronic Diseases Fuels Demand for Efficacy
Testing
Global Cancer Incidence by Region: 2018
Global Cancer Incidence by Type: 2018
EXHIBIT 10: Fatalities by Heart Conditions: Estimated
Percentage Breakdown for Cardiovascular Disease, Ischemic
Heart Disease, Stroke, and Others
EXHIBIT 3: Rising Diabetes Prevalence Presents Opportunity for
Cell Harvesting: Number of Adults (20-79) with Diabetes
(in Millions) by Region for 2017 and 2045

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Efficacy Testing
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Efficacy Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Efficacy Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Consumables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Consumables by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Consumables by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Instruments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Services by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Services by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Disinfectant
Efficacy Testing by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Disinfectant Efficacy
Testing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Disinfectant Efficacy
Testing by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 16: World Current & Future Analysis for Antimicrobial
Efficacy Testing by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Antimicrobial Efficacy
Testing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Antimicrobial Efficacy
Testing by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 19: World Current & Future Analysis for Pharmaceutical
Manufacturing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Pharmaceutical
Manufacturing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Pharmaceutical
Manufacturing by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 22: World Current & Future Analysis for Cosmetics &
Personal Care Products by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Cosmetics & Personal Care
Products by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Cosmetics & Personal
Care Products by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 25: World Current & Future Analysis for Medical Devices
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Medical Devices by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Medical Devices by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Consumables Segment Leads the Market

III. MARKET ANALYSIS

UNITED STATES
Table 28: USA Current & Future Analysis for Efficacy Testing by
Segment - Consumables, Instruments and Services - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 29: USA Historic Review for Efficacy Testing by Segment -
Consumables, Instruments and Services Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 30: USA 15-Year Perspective for Efficacy Testing by
Segment - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2012, 2020 & 2027

Table 31: USA Current & Future Analysis for Efficacy Testing by
Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Efficacy Testing by Type -
Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Efficacy Testing by Type -
Percentage Breakdown of Value Sales for Disinfectant Efficacy
Testing and Antimicrobial Efficacy Testing for the Years 2012,
2020 & 2027

Table 34: USA Current & Future Analysis for Efficacy Testing by
Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 35: USA Historic Review for Efficacy Testing by
Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 36: USA 15-Year Perspective for Efficacy Testing by
Application - Percentage Breakdown of Value Sales for
Pharmaceutical Manufacturing, Cosmetics & Personal Care
Products and Medical Devices for the Years 2012, 2020 & 2027

CANADA
Table 37: Canada Current & Future Analysis for Efficacy Testing
by Segment - Consumables, Instruments and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 38: Canada Historic Review for Efficacy Testing by
Segment - Consumables, Instruments and Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 39: Canada 15-Year Perspective for Efficacy Testing by
Segment - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2012, 2020 & 2027

Table 40: Canada Current & Future Analysis for Efficacy Testing
by Type - Disinfectant Efficacy Testing and Antimicrobial
Efficacy Testing - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 41: Canada Historic Review for Efficacy Testing by Type -
Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 42: Canada 15-Year Perspective for Efficacy Testing by
Type - Percentage Breakdown of Value Sales for Disinfectant
Efficacy Testing and Antimicrobial Efficacy Testing for the
Years 2012, 2020 & 2027

Table 43: Canada Current & Future Analysis for Efficacy Testing
by Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 44: Canada Historic Review for Efficacy Testing by
Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 45: Canada 15-Year Perspective for Efficacy Testing by
Application - Percentage Breakdown of Value Sales for
Pharmaceutical Manufacturing, Cosmetics & Personal Care
Products and Medical Devices for the Years 2012, 2020 & 2027

JAPAN
Table 46: Japan Current & Future Analysis for Efficacy Testing
by Segment - Consumables, Instruments and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 47: Japan Historic Review for Efficacy Testing by Segment -
Consumables, Instruments and Services Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 48: Japan 15-Year Perspective for Efficacy Testing by
Segment - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2012, 2020 & 2027

Table 49: Japan Current & Future Analysis for Efficacy Testing
by Type - Disinfectant Efficacy Testing and Antimicrobial
Efficacy Testing - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 50: Japan Historic Review for Efficacy Testing by Type -
Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 51: Japan 15-Year Perspective for Efficacy Testing by
Type - Percentage Breakdown of Value Sales for Disinfectant
Efficacy Testing and Antimicrobial Efficacy Testing for the
Years 2012, 2020 & 2027

Table 52: Japan Current & Future Analysis for Efficacy Testing
by Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 53: Japan Historic Review for Efficacy Testing by
Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 54: Japan 15-Year Perspective for Efficacy Testing by
Application - Percentage Breakdown of Value Sales for
Pharmaceutical Manufacturing, Cosmetics & Personal Care
Products and Medical Devices for the Years 2012, 2020 & 2027

CHINA
Table 55: China Current & Future Analysis for Efficacy Testing
by Segment - Consumables, Instruments and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 56: China Historic Review for Efficacy Testing by Segment -
Consumables, Instruments and Services Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 57: China 15-Year Perspective for Efficacy Testing by
Segment - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2012, 2020 & 2027

Table 58: China Current & Future Analysis for Efficacy Testing
by Type - Disinfectant Efficacy Testing and Antimicrobial
Efficacy Testing - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 59: China Historic Review for Efficacy Testing by Type -
Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 60: China 15-Year Perspective for Efficacy Testing by
Type - Percentage Breakdown of Value Sales for Disinfectant
Efficacy Testing and Antimicrobial Efficacy Testing for the
Years 2012, 2020 & 2027

Table 61: China Current & Future Analysis for Efficacy Testing
by Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 62: China Historic Review for Efficacy Testing by
Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 63: China 15-Year Perspective for Efficacy Testing by
Application - Percentage Breakdown of Value Sales for
Pharmaceutical Manufacturing, Cosmetics & Personal Care
Products and Medical Devices for the Years 2012, 2020 & 2027

EUROPE
Table 64: Europe Current & Future Analysis for Efficacy Testing
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027 and %
CAGR

Table 65: Europe Historic Review for Efficacy Testing by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 66: Europe 15-Year Perspective for Efficacy Testing by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 67: Europe Current & Future Analysis for Efficacy Testing
by Segment - Consumables, Instruments and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 68: Europe Historic Review for Efficacy Testing by
Segment - Consumables, Instruments and Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 69: Europe 15-Year Perspective for Efficacy Testing by
Segment - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2012, 2020 & 2027

Table 70: Europe Current & Future Analysis for Efficacy Testing
by Type - Disinfectant Efficacy Testing and Antimicrobial
Efficacy Testing - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 71: Europe Historic Review for Efficacy Testing by Type -
Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Efficacy Testing by
Type - Percentage Breakdown of Value Sales for Disinfectant
Efficacy Testing and Antimicrobial Efficacy Testing for the
Years 2012, 2020 & 2027

Table 73: Europe Current & Future Analysis for Efficacy Testing
by Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 74: Europe Historic Review for Efficacy Testing by
Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 75: Europe 15-Year Perspective for Efficacy Testing by
Application - Percentage Breakdown of Value Sales for
Pharmaceutical Manufacturing, Cosmetics & Personal Care
Products and Medical Devices for the Years 2012, 2020 & 2027

FRANCE
Table 76: France Current & Future Analysis for Efficacy Testing
by Segment - Consumables, Instruments and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 77: France Historic Review for Efficacy Testing by
Segment - Consumables, Instruments and Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 78: France 15-Year Perspective for Efficacy Testing by
Segment - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2012, 2020 & 2027

Table 79: France Current & Future Analysis for Efficacy Testing
by Type - Disinfectant Efficacy Testing and Antimicrobial
Efficacy Testing - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 80: France Historic Review for Efficacy Testing by Type -
Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 81: France 15-Year Perspective for Efficacy Testing by
Type - Percentage Breakdown of Value Sales for Disinfectant
Efficacy Testing and Antimicrobial Efficacy Testing for the
Years 2012, 2020 & 2027

Table 82: France Current & Future Analysis for Efficacy Testing
by Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 83: France Historic Review for Efficacy Testing by
Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 84: France 15-Year Perspective for Efficacy Testing by
Application - Percentage Breakdown of Value Sales for
Pharmaceutical Manufacturing, Cosmetics & Personal Care
Products and Medical Devices for the Years 2012, 2020 & 2027

GERMANY
Table 85: Germany Current & Future Analysis for Efficacy
Testing by Segment - Consumables, Instruments and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 86: Germany Historic Review for Efficacy Testing by
Segment - Consumables, Instruments and Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 87: Germany 15-Year Perspective for Efficacy Testing by
Segment - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2012, 2020 & 2027

Table 88: Germany Current & Future Analysis for Efficacy
Testing by Type - Disinfectant Efficacy Testing and
Antimicrobial Efficacy Testing - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 89: Germany Historic Review for Efficacy Testing by Type -
Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 90: Germany 15-Year Perspective for Efficacy Testing by
Type - Percentage Breakdown of Value Sales for Disinfectant
Efficacy Testing and Antimicrobial Efficacy Testing for the
Years 2012, 2020 & 2027

Table 91: Germany Current & Future Analysis for Efficacy
Testing by Application - Pharmaceutical Manufacturing,
Cosmetics & Personal Care Products and Medical Devices -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 92: Germany Historic Review for Efficacy Testing by
Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 93: Germany 15-Year Perspective for Efficacy Testing by
Application - Percentage Breakdown of Value Sales for
Pharmaceutical Manufacturing, Cosmetics & Personal Care
Products and Medical Devices for the Years 2012, 2020 & 2027

ITALY
Table 94: Italy Current & Future Analysis for Efficacy Testing
by Segment - Consumables, Instruments and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 95: Italy Historic Review for Efficacy Testing by Segment -
Consumables, Instruments and Services Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 96: Italy 15-Year Perspective for Efficacy Testing by
Segment - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2012, 2020 & 2027

Table 97: Italy Current & Future Analysis for Efficacy Testing
by Type - Disinfectant Efficacy Testing and Antimicrobial
Efficacy Testing - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 98: Italy Historic Review for Efficacy Testing by Type -
Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 99: Italy 15-Year Perspective for Efficacy Testing by
Type - Percentage Breakdown of Value Sales for Disinfectant
Efficacy Testing and Antimicrobial Efficacy Testing for the
Years 2012, 2020 & 2027

Table 100: Italy Current & Future Analysis for Efficacy Testing
by Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 101: Italy Historic Review for Efficacy Testing by
Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 102: Italy 15-Year Perspective for Efficacy Testing by
Application - Percentage Breakdown of Value Sales for
Pharmaceutical Manufacturing, Cosmetics & Personal Care
Products and Medical Devices for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 103: UK Current & Future Analysis for Efficacy Testing by
Segment - Consumables, Instruments and Services - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 104: UK Historic Review for Efficacy Testing by Segment -
Consumables, Instruments and Services Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 105: UK 15-Year Perspective for Efficacy Testing by
Segment - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2012, 2020 & 2027

Table 106: UK Current & Future Analysis for Efficacy Testing by
Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 107: UK Historic Review for Efficacy Testing by Type -
Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 108: UK 15-Year Perspective for Efficacy Testing by Type -
Percentage Breakdown of Value Sales for Disinfectant Efficacy
Testing and Antimicrobial Efficacy Testing for the Years 2012,
2020 & 2027

Table 109: UK Current & Future Analysis for Efficacy Testing by
Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 110: UK Historic Review for Efficacy Testing by
Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 111: UK 15-Year Perspective for Efficacy Testing by
Application - Percentage Breakdown of Value Sales for
Pharmaceutical Manufacturing, Cosmetics & Personal Care
Products and Medical Devices for the Years 2012, 2020 & 2027

SPAIN
Table 112: Spain Current & Future Analysis for Efficacy Testing
by Segment - Consumables, Instruments and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 113: Spain Historic Review for Efficacy Testing by
Segment - Consumables, Instruments and Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 114: Spain 15-Year Perspective for Efficacy Testing by
Segment - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2012, 2020 & 2027

Table 115: Spain Current & Future Analysis for Efficacy Testing
by Type - Disinfectant Efficacy Testing and Antimicrobial
Efficacy Testing - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 116: Spain Historic Review for Efficacy Testing by Type -
Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 117: Spain 15-Year Perspective for Efficacy Testing by
Type - Percentage Breakdown of Value Sales for Disinfectant
Efficacy Testing and Antimicrobial Efficacy Testing for the
Years 2012, 2020 & 2027

Table 118: Spain Current & Future Analysis for Efficacy Testing
by Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 119: Spain Historic Review for Efficacy Testing by
Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 120: Spain 15-Year Perspective for Efficacy Testing by
Application - Percentage Breakdown of Value Sales for
Pharmaceutical Manufacturing, Cosmetics & Personal Care
Products and Medical Devices for the Years 2012, 2020 & 2027

RUSSIA
Table 121: Russia Current & Future Analysis for Efficacy
Testing by Segment - Consumables, Instruments and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 122: Russia Historic Review for Efficacy Testing by
Segment - Consumables, Instruments and Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 123: Russia 15-Year Perspective for Efficacy Testing by
Segment - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2012, 2020 & 2027

Table 124: Russia Current & Future Analysis for Efficacy
Testing by Type - Disinfectant Efficacy Testing and
Antimicrobial Efficacy Testing - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 125: Russia Historic Review for Efficacy Testing by Type -
Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05798446/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting